<DOC>
	<DOC>NCT01863602</DOC>
	<brief_summary>The objectives of this post-marketing surveillance (PMS) are to grasp the actual use of lamotrigine tablets to collect safety information in the long-term use according to seizure type and concomitant antiepileptic drug (AED), and to confirm its efficacy.</brief_summary>
	<brief_title>Special Drug Use Investigation for LAMICTALÂ® (Long Term)</brief_title>
	<detailed_description />
	<mesh_term>Lamotrigine</mesh_term>
	<mesh_term>Anticonvulsants</mesh_term>
	<criteria>Subjects with epilepsy with partial seizures, tonicclonic seizuresm or generalized seizures of LennoxGastaut syndrome Subjects who are treated with lamotrigine tablets</criteria>
	<gender>All</gender>
	<minimum_age>N/A</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>November 2016</verification_date>
</DOC>